Toxic shock syndrome secondary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 2: Line 2:
{{Toxic shock syndrome}}
{{Toxic shock syndrome}}
== Overview: ==
== Overview: ==
Secondary prevention strategies following toxic shock syndrome (TSS) include [strategy 1], [strategy 2], and [strategy 3]
Secondary prevention strategies following toxic shock syndrome (TSS) include chemoprophylaxis for invasive group A streptococcus or staphylococcus carriers. Although it is still not certain to be helpful.


== Secondary Prevention ==
== Secondary Prevention ==
*'''First Sentences:'''
Several antibiotic regimens have been successful in eradicating group A streptococcus from the pharynx of chronic carriers (i.e., rifampin plus intramuscular benzathine penicillin or a 10-day course of a second-generation cephalosporin or clindamycin). However, there are limited data concerning chemoprophylaxis for severe invasive group A streptococcal or staphylococcal infections.<ref name="urlSevere Invasive Group A Streptococcal Infections: A Subject Review | AMERICAN ACADEMY OF PEDIATRICS | Pediatrics">{{cite web |url=http://pediatrics.aappublications.org/content/101/1/136.short |title=Severe Invasive Group A Streptococcal Infections: A Subject Review &#124; AMERICAN ACADEMY OF PEDIATRICS &#124; Pediatrics |format= |work= |accessdate=}}</ref><ref name="pmid19980033">{{cite journal |vauthors=Wylie A |title=Epithelioma of Soft Palate and Uvula |journal=Proc. R. Soc. Med. |volume=11 |issue=Laryngol Sect |pages=110–1 |year=1918 |pmid=19980033 |pmc=2066844 |doi= |url=}}</ref>
:.
'''OR'''
:The primary and secondary prevention strategies for [Disease Name] are the same.
Chemoprophylaxis of household contacts of STSS patients: Household contacts of people with STSS have a higher risk of invasive GAS infection compared to the general population. The Centers for Disease Control and Prevention have not made definite recommendations; some authors have recommended a 10-day course of cephalosporin{{WikiDoc Help Menu}}


Several regimens have been successful in eradicating group A streptococcus from the pharynx of chronic carriers (i.e., rifampin plus intramuscular benzathine penicillin or a 10-day course of a second-generation cephalosporin or clindamycin). [null <nowiki>[107]</nowiki>] However, there are limited data concerning chemoprophylaxis for severe invasive group A streptococcal or staphylococcal infections.<ref name="urlSevere Invasive Group A Streptococcal Infections: A Subject Review | AMERICAN ACADEMY OF PEDIATRICS | Pediatrics">{{cite web |url=http://pediatrics.aappublications.org/content/101/1/136.short |title=Severe Invasive Group A Streptococcal Infections: A Subject Review &#124; AMERICAN ACADEMY OF PEDIATRICS &#124; Pediatrics |format= |work= |accessdate=}}</ref>
__NOTOC__
 
Tanz RR, Poncher JR, Corydon KE, et al. Clindamycin treatment of chronic pharyngeal carriage of group a streptococci. J Pediatr. 1991;119:123-128__NOTOC__


==References==
==References==

Revision as of 16:01, 15 May 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]

Toxic shock syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxic Shock Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxic shock syndrome secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxic shock syndrome secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxic shock syndrome secondary prevention

CDC on Toxic shock syndrome secondary prevention

Toxic shock syndrome secondary prevention in the news

Blogs on Toxic shock syndrome secondary prevention

Directions to Hospitals Treating Toxic shock syndrome

Risk calculators and risk factors for Toxic shock syndrome secondary prevention

Overview:

Secondary prevention strategies following toxic shock syndrome (TSS) include chemoprophylaxis for invasive group A streptococcus or staphylococcus carriers. Although it is still not certain to be helpful.

Secondary Prevention

Several antibiotic regimens have been successful in eradicating group A streptococcus from the pharynx of chronic carriers (i.e., rifampin plus intramuscular benzathine penicillin or a 10-day course of a second-generation cephalosporin or clindamycin). However, there are limited data concerning chemoprophylaxis for severe invasive group A streptococcal or staphylococcal infections.[1][2]


References

  1. "Severe Invasive Group A Streptococcal Infections: A Subject Review | AMERICAN ACADEMY OF PEDIATRICS | Pediatrics".
  2. Wylie A (1918). "Epithelioma of Soft Palate and Uvula". Proc. R. Soc. Med. 11 (Laryngol Sect): 110–1. PMC 2066844. PMID 19980033.